North America

Over the first half of the fourth quarter, Epinephrine prices gradually increased at a moderate rate in North America. End-user demand from the pharmaceutical industry kept Epinephrine costs on the sturdy end. Additionally, there was a steep decline in supply chain disruption in the six months leading up to November across several measures, including shipping costs, which further strengthened the Epinephrine market in an upward direction. However, towards the end of q4, they started to fall precipitously due to a major decrease in their offtakes and New year breaks. Prices for Epinephrine stayed on the North side, with the settlement at USD 2448000 /MT CFR Los Angeles.


In the fourth quarter of 2022, Epinephrine prices in the Asia Pacific area, particularly in China, plummet by the end of December. However, prices remained on the upper side throughout the initial half of q4 due to increased downstream demand balanced with adequate supplies among market participants. On the other hand, the ease in supply chain disruption in November compared to October, including the lower shipping costs, encouraged the traders and suppliers to raise their quotations. With the year ending 2022 concluding, China's production activities started to decline, particularly after November, due to an increase in COVID-19 instances and a reduction in freight costs, supporting Epinephrine's price trend in China. Overall, the Epinephrine costs noted in the middle of the fourth were assembled at USD 2318500/MT FOB Shanghai in China.


The Prices of Epinephrine market in Europe followed a similar trajectory to that in Asia Pacific in the fourth quarter of 2022. Due to a rise in demand from the end-user pharmaceutical business, the market trend started off well up until November and reached an assembly price of USD 2491500/MT CFR Hamburg in Germany. After November, Epinephrine inquiries from the downstream industry started to decline dramatically, which reinforced the drug's weaker price trend because market participants had plenty of supply and little to no demand. Also, fresher quotations declined in December because of suppliers' high stock levels brought on by the market closure.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.